The downstream health savings from that magnitude of weight loss include: | Potential Savings | Annual Value | |-------------------|-------------| | Reduced diabetes risk/medications -- see [GLP-1 comparison chart](/guides/glp1-medications-comparison-chart-guide) for all options | $2,000-6,000 | | Blood pressure medication reduction | $600-1,800 | | Sleep apnea treatment reduction | $1,200-3,600 | | Avoided bariatric surgery | $20,000-35,000 (one-time) | | Reduced joint replacement risk | $30,000-50,000 (lifetime) | Against a first-year cost of $3,000-5,500 for compounded retatrutide, the financial case is strong for patients who respond well
Osete JR, Akkouh IA, de Assis DR, Szabo A, Frei E, Hughes T, et al
List the first-line agent(s) for controlling hypertension and dyslipidemia associated with diabetes
The candidate is currently in Phase IIb development
Ozempic is administered just once a week
Guzik TJ, Touyz RM